p38MAPK inhibition: a new combined approach to reduce neuroblastoma resistance under etoposide treatment

por Marengo, B, De Ciucis, C G, Ricciarelli, R, Furfaro, A L, Colla, R, Canepa, E, Traverso, N, Marinari, U M, Pronzato, M A, Domenicotti, C
Publicado 2013